Prepare for your visit

Kate Marshall Mount

Nurse Practitioner · Mobile, AL · NPI 1629513023

One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.

What was reported

$3,879.55

in general payments reported to CMS, 2019-2025 · $1,368 in 2025

The $1,368 reported for 2025 was more than what 89% of Nurse Practitioner providers received nationally (typical 2025 total: $174).

Who reported paying

General payments only, top 6 by amount.

Novartis Pharmaceuticals Corporation $836.16
Actelion Pharmaceuticals US, INC. $477.93
Pfizer INC. $477.42
Scpharmaceuticals INC. $471.84
Boehringer Ingelheim Pharmaceuticals, INC. $450.36
Janssen Pharmaceuticals, INC $302.60

Drugs and devices associated with these payments

Furoscix Leqvio Opsumit Uptravi Eliquis Nurtec Odt Synergy Ablation System Jardiance Vyndaqel Barostim Neo System Entresto Paxlovid

Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.

Questions you might ask

I saw Kate Mount listed in the CMS Open Payments database. Can you tell me about your work with those companies?
Is there a generic or alternative to this medication, and would it work as well for me?
What made you choose this particular treatment for my situation?

These are normal questions. A good clinician will welcome them.

Notes

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.

GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/10474052/kate-marshall-mount